secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2021-07-06T23:59:59+00:00
Accession:  0001193125-21-208710
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Abbas Hussain resigns from Teva board effective July 6, 2021
---------------------------------------------------------------------

- Abbas Hussain resigned from Teva's Board effective July 6, 2021.
- He served as a director since September 2020 and was on Audit, Finance and Investment, and Science and Technology committees.
- Resignation due to his new role as CEO of Vifor Pharma Group, not due to any disagreements with Teva.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312521208710/0001193125-21-208710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312521208710/d111873d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-208710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer